Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.
作者： Laura L. Kovanda , Thomas J. Walsh , Daniel K. Benjamin , Antonio Arrieta , David A. Kaufman
DOI: 10.1097/INF.0000000000001957
关键词:
摘要: Background:Neonatal candidiasis causes significant morbidity and mortality in high risk infants. The micafungin dosage regimen of 10 mg/kg established for the treatment neonatal is based on a laboratory animal model hematogenous Candida meningoencephalitis pharmacokine
sci-hub.se 参考文章(30)
Kevin M. Watt, Michael Cohen-Wolkowiez, Robert M. Ward, Daniel K. Benjamin, Commentary: pediatric antifungal drug development: lessons learned and recommendations for the future. Pediatric Infectious Disease Journal. ,vol. 31, pp. 635- 637 ,(2012) , 10.1097/INF.0B013E31824F8426
Amanda B. Arsenault, Joseph M. Bliss, Neonatal Candidiasis: New Insights into an Old Problem at a Unique Host-Pathogen Interface Current Fungal Infection Reports. ,vol. 9, pp. 246- 252 ,(2015) , 10.1007/S12281-015-0238-X
WW Hope, E Castagnola, AH Groll, E Roilides, M Akova, MC Arendrup, SEVTAP Arikan‐Akdagli, Matteo Bassetti, J Bille, OA Cornely, M Cuenca‐Estrella, J Peter Donnelly, J Garbino, R Herbrecht, HE Jensen, BJ Kullberg, C Lass‐Flörl, O Lortholary, Wouter Meersseman, G Petrikkos, MD Richardson, PE Verweij, C Viscoli, AJ Ullmann, ESCMID Fungal Infection Study Group (EFISG), ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp Clinical Microbiology and Infection. ,vol. 18, pp. 38- 52 ,(2012) , 10.1111/1469-0691.12040
Daniel K Benjamin Jr, Barbara J Stoll, Avory A Fanaroff, Scott A McDonald, William Oh, Rosemary D Higgins, Shahnaz Duara, Kenneth Poole, Abbot Laptook, Ronald Goldberg, National Institute of Child Health and Human Development Neonatal Research Network, None, Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months Pediatrics. ,vol. 117, pp. 84- 92 ,(2006) , 10.1542/PEDS.2004-2292
D K Benjamin, P B Smith, A Arrieta, L Castro, P J Sánchez, D Kaufman, L J Arnold, L L Kovanda, T Sawamoto, D N Buell, W W Hope, T J Walsh, Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clinical Pharmacology & Therapeutics. ,vol. 87, pp. 93- 99 ,(2010) , 10.1038/CLPT.2009.200
Daniel K Benjamin, Elizabeth DeLong, Charles M Cotten, Harmony P Garges, William J Steinbach, Reese H Clark, Mortality Following Blood Culture in Premature Infants: Increased with Gram-negative Bacteremia and Candidemia, but Not Gram-positive Bacteremia Journal of Perinatology. ,vol. 24, pp. 175- 180 ,(2004) , 10.1038/SJ.JP.7211068
Gloria P. Heresi, Dale R. Gerstmann, Michael D. Reed, John N. van den Anker, Jeffrey L. Blumer, Laura Kovanda, James J. Keirns, Donald N. Buell, Gregory L. Kearns, The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants The Pediatric Infectious Disease Journal. ,vol. 25, pp. 1110- 1115 ,(2006) , 10.1097/01.INF.0000245103.07614.E1
S. Aliaga, R. H. Clark, M. Laughon, T. J. Walsh, W. W. Hope, D. K. Benjamin, D. Kaufman, A. Arrieta, D. K. Benjamin, P. B. Smith, Changes in the Incidence of Candidiasis in Neonatal Intensive Care Units Pediatrics. ,vol. 133, pp. 236- 242 ,(2014) , 10.1542/PEDS.2013-0671
Antonio C. Arrieta, Philip Maddison, Andreas H. Groll, Safety of micafungin in pediatric clinical trials. Pediatric Infectious Disease Journal. ,vol. 30, ,(2011) , 10.1097/INF.0B013E3182127EAF
Michael N. Neely, Michael G. van Guilder, Walter M. Yamada, Alan Schumitzky, Roger W. Jelliffe, Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R Therapeutic Drug Monitoring. ,vol. 34, pp. 467- 476 ,(2012) , 10.1097/FTD.0B013E31825C4BA6